Neuron Biopharma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neuron Biopharma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11498
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neuron Biopharma SA (NBP) is a biotechnology company that discovers and develops biosolutions. The company offers pharmaceutical compounds to prevent and treat various neurodegenerative diseases. It discovers and assesses nutraceuticals, and development of diagnostic methods for the treatment of Alzheimer’s disease. NBP’s pharmaceutical products include NST0037, NST0076, NST0078, and NPS0158/163. The company develops research projects for public institutions, biotechnological, pharmaceutical, agro-food and animal health area, among others. It conducts research on the implications of the regulation of cholesterol in the brain. The company operates through universities and pharmaceutical companies. It also operates in the US through its subsidiary. NBP is headquartered in Granada, Spain.

Neuron Biopharma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuron Biopharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neuron Biopharma SA, Medical Devices Deals, 2012 to YTD 2018 9
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Neuron Bio and CIEN Foundation Enter into Agreement 11
Equity Offering 12
Neuron Bio Raises USD3.4 Million in Rights Offering of Shares 12
Neuron Bio Raises USD1 Million in Rights Offering of Shares 13
Neuron Bio to Raise USD2 Million in Private Placement of Shares 14
Neuron Biopharma SA – Key Competitors 15
Neuron Biopharma SA – Key Employees 16
Neuron Biopharma SA – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Key Facts 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuron Biopharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuron Biopharma SA, Deals By Therapy Area, 2012 to YTD 2018 8
Neuron Biopharma SA, Medical Devices Deals, 2012 to YTD 2018 9
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Neuron Bio and CIEN Foundation Enter into Agreement 11
Neuron Bio Raises USD3.4 Million in Rights Offering of Shares 12
Neuron Bio Raises USD1 Million in Rights Offering of Shares 13
Neuron Bio to Raise USD2 Million in Private Placement of Shares 14
Neuron Biopharma SA, Key Competitors 15
Neuron Biopharma SA, Key Employees 16
Neuron Biopharma SA, Other Locations 17

List of Figures
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuron Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neuron Biopharma SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Neuron Biopharma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Retail Food Group Limited (Foodservice):企業の戦略・SWOT・財務情報
    Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Good Energy Group PLC (GOOD)-エネルギー分野:企業M&A・提携分析
    Summary Good Energy Group PLC (Good Energy) is a vertically integrated utility, with operations in electricity and natural gas distribution businesses. It sources entire electricity from renewable sources including its own renewable generation assets, other renewable power producers and directly fro …
  • Quadrise Fuels International Plc (QFI)-石油・ガス分野:企業M&A・提携分析
    Summary Quadrise Fuels International Plc (QFI), formerly Zareba Plc, is an oil-in-water emulsified fuel developer that manufactures and markets MSAR (Multiphase Superfine Atomised Residue), an emulsion fuel as a low cost substitute for conventional heavy fuel oil (HFO) for use in power generation pl …
  • Hydro Ottawa Holding Inc:企業の戦略的SWOT分析
    Hydro Ottawa Holding Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Callon Petroleum Co (CPE):企業の財務・戦略的SWOT分析
    Summary Callon Petroleum Co (CPC) is an oil and gas company that offers building reserves and production of onshore and offshore oil and natural gas. The company carries out acquisition, development, exploration, and exploitation of unconventional onshore, oil, and natural gas reserves. It operates …
  • Outokumpu Oyj:企業のM&A・事業提携・投資動向
    Outokumpu Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Outokumpu Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • OraMetrix Inc-医療機器分野:企業M&A・提携分析
    Summary OraMetrix Inc (OraMetrix) is a healthcare technology company that provides 3-D technology solutions. The company offers orthodontic treatment system and digital lingual orthodontic system. Its product allows the use of precision digital tools throughout the orthodontic treatment process incl …
  • Mylan Laboratories Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Mylan Laboratories Ltd (Mylan), a subsidiary of Mylan NV is a pharmaceutical company that manufactures and supplies API products. The company offers HIV care products for the treatment of HIV/AIDS. It provides women’s care products for therapies such as hormone replacement therapy, infertili …
  • Neurovance Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neurovance Inc (Neurovance) is a clinical stage neuroscience focused company that develops centanafadine (CTN) SR for adult and pediatric Attention Deficit Hyperactivity Disorder (ADHD). CTN, formerly EB-1020, is a novel triple reuptake inhibitor that acts as a functional hybrid with activit …
  • Hitachi Zosen Corp (7004):電力:M&Aディール及び事業提携情報
    Summary Hitachi Zosen Corp (Hitz) is an industrial and engineering company. It designs, constructs and operates refuse incineration and recycling facilities, pressure vessels, marine diesel engines, and press machines, and other process machine. The company also provides after-sales servicing and ma …
  • Sv. Sv. Konstantin I Elena Holding Ad
    Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report Summary Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Straumann Holding AG (STMN):企業の財務・戦略的SWOT分析
    Straumann Holding AG (STMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Global Telecom Holding SAE:企業の戦略的SWOT分析
    Global Telecom Holding SAE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Enzo Clinical Labs Inc-医療機器分野:企業M&A・提携分析
    Summary Enzo Clinical Labs Inc (Enzo Clinical), a subsidiary of Enzo Biochem Inc is a medical laboratory that offers testing services. The laboratory develops technologies in the areas of gene regulation and gene modification, biomedical and pharmaceutical research markets. It offers physicians seve …
  • Greenyard NV:企業の戦略・SWOT・財務分析
    Greenyard NV - Strategy, SWOT and Corporate Finance Report Summary Greenyard NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Piramal Enterprises Ltd (PEL):医療機器:M&Aディール及び事業提携情報
    Summary Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. I …
  • InterSystems Corp:企業の戦略的SWOT分析
    InterSystems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Matica Technologies AG:企業の戦略的SWOT分析
    Matica Technologies AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Osmotica Pharmaceutical Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Osmotica Pharmaceutical Corp (Osmotica) is a pharmaceutical company that specializes in drug delivery technologies and neurology based therapies. The company provides product portfolio such as nifedipine, oxybutynin, venlafaxine and desvenlafaxine, among others. It offers capabilities such a …
  • Mologic Ltd:企業の製品パイプライン分析2018
    Summary Mologic Ltd (Mologic) is a medical device company that designs, develops, manufactures and markets in vitro diagnostic medical devices. The company provides products such as bacterial vaginosis test kit, peritoneal dialysis test, lateral flow kit, desmosine ELISA kit and FMLP ELISA kit, amon …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆